Deficits of glutamate transmission in the striatum of experimental hemiballism

Neuroscience

Volumn 143, Issue 1, 2006, Pages 213-221

  Centonze, D ^a,b   Rossi, S ^a,b   Gubellini, P ^c   De Chiara, V ^a,b   Tscherter, A ^a,b   Prosperetti, C ^a,b   Picconi, B ^b   Bernardi, G ^a,b   Calabresi, P ^b,d   Baunez, C ^e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c CNRS   (France)

^d UNIVERSITY OF PERUGIA   (Italy)

^e AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

electrophysiology; hyperkinetic disorders; mEPSC; sEPSC; subthalamic nucleus

Indexed keywords

4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; GLUTAMIC ACID; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROPHYSIOLOGY; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; HEMIBALLISM; INHIBITORY POSTSYNAPTIC POTENTIAL; NERVE CELL MEMBRANE POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SUBTHALAMIC NUCLEUS;

ANESTHETICS, LOCAL; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE ANTAGONISTS; DYSKINESIAS; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; GLUTAMIC ACID; INHIBITORY POSTSYNAPTIC POTENTIALS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; SULPIRIDE; SYNAPTIC TRANSMISSION; TETRODOTOXIN; TRIAZINES; TRIAZOLES;

EID: 33751036242     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.07.024     Document Type: Article

References (39)

1. Baunez C., Nieoullon A., and Amalric M. In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit. J Neurosci 15 (1995) 6531-6541
2. Baunez C., and Robbins T.W. Bilateral lesions of the subthalamic nucleus induce multiple deficits in an attentional task in rats. Eur J Neurosci 9 (1997) 2086-2099
3. Baunez C., Amalric M., and Robbins T.W. Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus. J Neurosci 22 (2002) 562-568
4. Blandini F., and Greenamyre J.T. Effect of subthalamic nucleus lesion on mitochondrial enzyme activity in rat basal ganglia. Brain Res 669 (1995) 59-66
5. Blum D., Galas M.C., Pintor A., Brouillet E., Ledent C., Muller C.E., Bantubungi K., Galluzzo M., Gall D., Cuvelier L., Rolland A.S., Popoli P., and Schiffmann S.N. A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the Neuroprotective potential of A2A antagonists. J Neurosci 23 (2003) 5361-5369
6. Calabresi P., Mercuri N.B., Sancesario G., and Bernardi G. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease. Brain 116 (1993) 433-452
7. Calabresi P., Gubellini P., Picconi B., Centonze D., Pisani A., Bonsi P., Greengard P., Hipskind R.A., Borrelli E., and Bernardi G. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. J Neurosci 21 (2001) 5110-5120
8. Carpenter M.B., Carleton S.C., Keller J.T., and Conte P. Connections of the subthalamic nucleus in the monkey. Brain Res 224 (1981) 1-29
9. Centonze D., Picconi B., Baunez C., Borrelli E., Pisani A., Bernardi G., and Calabresi P. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology 26 (2002) 164-175
10. Centonze D., Grande C., Usiello A., Gubellini P., Erbs E., Martin A.B., Pisani A., Tognazzi N., Bernardi G., Moratalla R., Borrelli E., and Calabresi P. Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons. J Neurosci 23 (2003) 6245-6254
11. Centonze D., Gubellini P., Rossi S., Picconi B., Pisani A., Bernardi G., Calabresi P., and Baunez C. Subthalamic nucleus lesion reverses motor abnormalities and striatal glutamatergic overactivity in experimental parkinsonism. Neuroscience 133 (2005) 831-840
12. Centonze D., Rossi S., Prosperetti C., Tscherter A., Bernardi G., Maccarrone M., and Calabresi P. Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice. Biol Psychiatry 57 (2005) 1583-1589
13. Cepeda C., Hurst R.S., Calvert C.R., Hernandez-Echeagaray E., Nguyen O.K., Jocoy E., Christian L.J., Ariano M.A., and Levine M.S. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease. J Neurosci 23 (2003) 961-969
14. Cepeda C., Starling A.J., Wu N., Nguyen O.K., Uzgil B., Soda T., André V.M., Ariano M.A., and Levine M.S. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. J Neurosci Res 78 (2004) 855-867
15. Charvin D., Vanhoutte P., Pages C., Borrelli E., and Caboche J. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation. Proc Natl Acad Sci U S A 102 (2005) 12218-12223
16. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13 (1990) 281-285
17. Dube L., Smith A.D., and Bolam J.P. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum. J Comp Neurol 267 (1988) 455-471
18. Gianfriddo M., Corsi C., Melani A., Pezzola A., Reggio R., Popoli P., and Pedata F. Adenosine A(2A) antagonism increases striatal glutamate outflow in the quinolinic acid rat model of Huntington's disease. Brain Res 979 (2003) 225-229
19. Graybiel A.M. The basal ganglia. Trends Neurosci 18 (1995) 60-62
20. Gubellini P., Picconi B., Bari M., Battista N., Calabresi P., Centonze D., Bernardi G., Finazzi-Agro A., and Maccarrone M. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci 22 (2002) 6900-6907
21. Guridi J., and Obeso J.A. The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. Brain 124 (2001) 5-19
22. Henderson J.M., Annett L.E., Ryan L.J., Chiang W., Hidaka S., Torres E.M., and Dunnett S.B. Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat. Eur J Neurosci 11 (1999) 2749-2757
23. Jiang Z.G., and North R.A. Membrane properties and synaptic responses of rat striatal neurones in vitro. J Physiol 443 (1991) 533-553
24. Kafetzopoulos E., and Papadopoulos G. Turning behavior after unilateral lesion of the subthalamic nucleus in the rat. Behav Brain Res 8 (1983) 217-223
25. Mitchell I.J., Cooper A.J., and Griffiths M.R. The selective vulnerability of striatopallidal neurons. Prog Neurobiol 59 (1999) 691-719
26. Nisenbaum E.S., and Berger T.W. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs. I. In vivo analysis. Neuroscience 48 (1992) 561-578
27. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Lanciego J.L., Artieda J., Gonzalo N., and Olanow C.W. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23 (2000) S8-S19
28. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20 (1995) 128-154
29. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd edition (1986), Academic Press, London
30. Phillips J.M., Latimer M.P., Gupta S., Winn P., and Brown V.J. Excitotoxic lesions of the subthalamic nucleus ameliorate asymmetry induced by striatal dopamine depletion in the rat. Behav Brain Res 90 (1998) 73-77
31. Postuma R.B., and Lang A.E. Hemiballism: revisiting a classic disorder. Lancet Neurol 2 (2003) 661-668
32. Stern E.A., Jaeger D., and Wilson C.J. Membrane potential synchrony of simultaneously recorded striatal spiny neurons in vivo. Nature 394 (1998) 475-478
33. Takada M., Nishihama M.S., Nishihama C.C., and Hattori T. Two separate neuronal populations of the rat subthalamic nucleus project to the basal ganglia and pedunculopontine tegmental region. Brain Res 442 (1988) 72-80
34. Tang K., Low M.J., Grandy D.K., and Lovinger D.M. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci U S A 98 (2001) 1255-1260
35. Touchon J.C., Moore C., Frederickson J., and Meshul C.K. Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations. Synapse 51 (2004) 287-298
36. Tscherter A., Rossi S., Centonze D., Borsini F., and Calabresi P. Interaction of adenosine A2A and dopamine D2 receptors modulates glutamatergic corticostriatal transmission. FENS Abstr 3 (2006) A075 11.
37. Varani K., Rigamonti D., Sipione S., Camurri A., Borea P.A., Cattabeni F., Abbracchio M.P., and Cattaneo E. Aberrant amplification of A(2A) receptor signaling in striatal cells expressing mutant huntingtin. FASEB J 15 (2001) 1245-1247
38. Varani K., Abbracchio M.P., Cannella M., Cislaghi G., Giallonardo P., Mariotti C., Cattabriga E., Cattabeni F., Borea P.A., Squitieri F., and Cattaneo E. Aberrant A2A receptor function in peripheral blood cells in Huntington's disease. FASEB J 17 (2003) 2148-2150
39. Wilson C.J., and Kawaguchi Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci 16 (1996) 2397-2410